STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CRWV (NASDAQ) resale filing: 40,000 Founders shares registered for sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV filed a Form 144 registering 40,000 shares of Common Stock for resale, with an aggregate amount listed as $4,718,000.00 and an effective date of 06/22/2026. The shares are described as Founders Shares dated 02/25/2019.

The filing lists multiple prior 10b5-1 sales by related parties on several dates (examples include large sales in April and June 2026), indicating planned, prearranged dispositions under trading plans.

Positive

  • None.

Negative

  • None.

Insights

Routine resale under Rule 144/10b5-1; procedural rather than operational news.

The filing registers 40,000 shares for resale dated 06/22/2026, labeled as Founders Shares from 02/25/2019. This is a regulatory notice that permits covered holders to sell under Rule 144 mechanics.

Multiple entries show 10b5-1 sales by related entities on specific dates in 2026; timing and cash‑flow recipients are not detailed in the excerpt, and market impact depends on actual sales execution by holders.

Registered shares 40,000 shares registration effective <date>06/22/2026</date>
Aggregate amount listed $4,718,000.00 associated with the 40,000 shares
Founders Shares date 02/25/2019 classification of the registered shares
Shares outstanding (excerpt) 447,573,939 figure shown in the filing excerpt (listed with date <date>06/22/2026</date>)
Example 10b5-1 sale 200,000 shares sale on <date>04/27/2026</date> amounting to <money>$21,806,780.00</money>
Example 10b5-1 sale 144,000 shares sale on <date>06/15/2026</date> amounting to <money>$15,450,595.20</money>
10b5-1 regulatory
"10b5-1 Sales for BRANNIN MCBEE 06/15/2026"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Founders Shares market
"Founders Shares | Issuer | 40000 | 02/25/2019"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Form 144 regulatory
"Filer Information | Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Resale registration regulatory
"Securities To Be Sold | Common | 40000"
Resale registration is the formal filing with securities regulators that allows previously restricted or privately held shares to be sold publicly. Think of it as getting official permission to unlock and list a sealed package of stock so it can be traded openly; that matters to investors because it increases liquidity, can change the number of shares available on the market, and reduces legal risk for sellers, all of which can affect a company’s share price.

FAQ

What does the CRWV Form 144 disclose?
It discloses registration to resell 40,000 shares with an aggregate value of $4,718,000.00. The filing lists the shares as Founders Shares dated 02/25/2019 and shows multiple related 10b5-1 sales in 2026.

Who appears to be selling CRWV shares under the filing?
The excerpt shows sales attributed to named individuals and trusts (e.g., Brannin McBee, Meghan Bennett, related trusts). Many entries are labeled as 10b5-1 sales on specified 2026 dates, indicating prearranged plans.

Does the Form 144 state proceeds recipient or use of proceeds?
The filing lists aggregate dollar amounts for specific sales but does not state a use of proceeds or who receives the cash. The excerpt ties dollar figures to each sale entry only.

Are the registered shares part of a broader selling program?
The filing registers 40,000 shares and the excerpt separately lists numerous prior 10b5-1 sales in 2026. These entries indicate ongoing, prearranged dispositions, though a single consolidated program description is not provided.

What is the timing noted in the CRWV filing?
The registration shows an effective date of 06/22/2026 for the 40,000 shares and the Founders Shares date of 02/25/2019. Multiple sales in the excerpt are dated across March–June 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR